ID CTL2_MOUSE Reviewed; 706 AA. AC Q8BY89; Q8K2F1; DT 30-AUG-2005, integrated into UniProtKB/Swiss-Prot. DT 21-SEP-2011, sequence version 2. DT 27-MAR-2024, entry version 146. DE RecName: Full=Choline transporter-like protein 2; DE AltName: Full=Solute carrier family 44 member 2; GN Name=Slc44a2; Synonyms=Ctl2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC STRAIN=C57BL/6J; TISSUE=Thymus; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=Czech II; TISSUE=Mammary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-200. RC TISSUE=Myoblast; RX PubMed=19656770; DOI=10.1074/mcp.m900195-mcp200; RA Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D., RA Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B.; RT "The mouse C2C12 myoblast cell surface N-linked glycoproteome: RT identification, glycosite occupancy, and membrane orientation."; RL Mol. Cell. Proteomics 8:2555-2569(2009). RN [4] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-200. RX PubMed=19349973; DOI=10.1038/nbt.1532; RA Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., RA Schiess R., Aebersold R., Watts J.D.; RT "Mass-spectrometric identification and relative quantification of N-linked RT cell surface glycoproteins."; RL Nat. Biotechnol. 27:378-386(2009). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Heart, Kidney, Lung, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP CHARACTERIZATION OF ISOFORMS 1 AND 3, ALTERNATIVE PROMOTER USAGE, TISSUE RP SPECIFICITY, AND GLYCOSYLATION. RX PubMed=20665236; DOI=10.1007/s10930-010-9268-y; RA Kommareddi P.K., Nair T.S., Thang L.V., Galano M.M., Babu E., Ganapathy V., RA Kanazawa T., McHugh J.B., Carey T.E.; RT "Isoforms, expression, glycosylation, and tissue distribution of RT CTL2/SLC44A2."; RL Protein J. 29:417-426(2010). CC -!- FUNCTION: Choline/H+ antiporter, mainly in mitochodria. Also acts as a CC low-affinity ethanolamine/H+ antiporter, regulating the supply of CC extracellular ethanolamine (Etn) for the CDP-Etn pathway, redistribute CC intracellular Etn and balance the CDP-Cho and CDP-Etn arms of the CC Kennedy pathway. {ECO:0000250|UniProtKB:Q8IWA5}. CC -!- CATALYTIC ACTIVITY: CC Reaction=choline(out) + n H(+)(in) = choline(in) + n H(+)(out); CC Xref=Rhea:RHEA:75463, ChEBI:CHEBI:15354, ChEBI:CHEBI:15378; CC Evidence={ECO:0000250|UniProtKB:Q8IWA5}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ethanolamine(out) + n H(+)(in) = ethanolamine(in) + n CC H(+)(out); Xref=Rhea:RHEA:75467, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57603; Evidence={ECO:0000250|UniProtKB:Q8IWA5}; CC -!- SUBUNIT: Interacts with COCH. {ECO:0000250|UniProtKB:Q8IWA5}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8IWA5}; CC Multi-pass membrane protein {ECO:0000255}. Mitochondrion outer membrane CC {ECO:0000250|UniProtKB:Q8IWA5}; Multi-pass membrane protein CC {ECO:0000255}. Note=Mainly expressed in mitochondria. CC {ECO:0000250|UniProtKB:B4F795}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative promoter usage; Named isoforms=2; CC Name=1; Synonyms=CTL2a, CTL2P2; CC IsoId=Q8BY89-1; Sequence=Displayed; CC Name=2; Synonyms=CTL2b, CTL2P1; CC IsoId=Q8BY89-2; Sequence=VSP_015432; CC -!- TISSUE SPECIFICITY: Expressed at high levels in lung, colon, inner ear CC and spleen (at protein level). Progressively lower levels in brain, CC tongue, liver and kidney (at protein level). In the kidney, prominent CC expression in glomeruli in the lining of Bowman's capsule and on the CC mesangial cells adjacent to the vessels within the glomerulus (at CC protein level). Strongly expressed on the membranes of splenocytes and CC in lung parenchyme (at protein level). {ECO:0000269|PubMed:20665236}. CC -!- TISSUE SPECIFICITY: [Isoform 1]: Expressed at higher levels than CC isoform 2 in colon, heart, kidney, lung, cochlea, tongue and muscle, as CC well as in the inner ear. {ECO:0000269|PubMed:20665236}. CC -!- TISSUE SPECIFICITY: [Isoform 2]: Predominantly expressed in brain, CC liver and spleen. {ECO:0000269|PubMed:20665236}. CC -!- PTM: Glycosylated, glycosylation differs from tissue to tissue. The CC molecular mass of the mature glycosylated protein is highest in kidney, CC followed by lung, colon and spleen, then brain and tongue. CC {ECO:0000269|PubMed:20665236}. CC -!- MISCELLANEOUS: [Isoform 2]: Produced by alternative promoter usage. CC {ECO:0000305}. CC -!- SIMILARITY: Belongs to the CTL (choline transporter-like) family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK041533; BAC30976.1; -; mRNA. DR EMBL; AK048648; BAC33409.1; -; mRNA. DR EMBL; BC031535; AAH31535.1; -; mRNA. DR CCDS; CCDS22903.1; -. [Q8BY89-1] DR CCDS; CCDS90511.1; -. [Q8BY89-2] DR RefSeq; NP_001186115.1; NM_001199186.1. [Q8BY89-2] DR RefSeq; NP_690021.1; NM_152808.3. [Q8BY89-1] DR AlphaFoldDB; Q8BY89; -. DR BioGRID; 212989; 4. DR STRING; 10090.ENSMUSP00000034697; -. DR TCDB; 2.A.92.1.2; the choline transporter-like (ctl) family. DR GlyConnect; 2211; 3 N-Linked glycans (2 sites). DR GlyCosmos; Q8BY89; 3 sites, 3 glycans. DR GlyGen; Q8BY89; 4 sites, 3 N-linked glycans (2 sites), 1 O-linked glycan (1 site). DR iPTMnet; Q8BY89; -. DR PhosphoSitePlus; Q8BY89; -. DR SwissPalm; Q8BY89; -. DR EPD; Q8BY89; -. DR jPOST; Q8BY89; -. DR MaxQB; Q8BY89; -. DR PaxDb; 10090-ENSMUSP00000034697; -. DR PeptideAtlas; Q8BY89; -. DR ProteomicsDB; 277919; -. [Q8BY89-1] DR ProteomicsDB; 277920; -. [Q8BY89-2] DR Pumba; Q8BY89; -. DR Antibodypedia; 1011; 150 antibodies from 24 providers. DR DNASU; 68682; -. DR Ensembl; ENSMUST00000034697.8; ENSMUSP00000034697.8; ENSMUSG00000057193.9. [Q8BY89-1] DR Ensembl; ENSMUST00000217461.2; ENSMUSP00000150147.2; ENSMUSG00000057193.9. [Q8BY89-2] DR GeneID; 68682; -. DR KEGG; mmu:68682; -. DR UCSC; uc009okz.2; mouse. [Q8BY89-2] DR UCSC; uc009ola.2; mouse. [Q8BY89-1] DR AGR; MGI:1915932; -. DR CTD; 57153; -. DR MGI; MGI:1915932; Slc44a2. DR VEuPathDB; HostDB:ENSMUSG00000057193; -. DR eggNOG; KOG1362; Eukaryota. DR GeneTree; ENSGT00940000158178; -. DR HOGENOM; CLU_017181_3_1_1; -. DR InParanoid; Q8BY89; -. DR OMA; CIAYWAC; -. DR OrthoDB; 551961at2759; -. DR PhylomeDB; Q8BY89; -. DR TreeFam; TF313325; -. DR Reactome; R-MMU-1483191; Synthesis of PC. DR Reactome; R-MMU-425366; Transport of bile salts and organic acids, metal ions and amine compounds. DR Reactome; R-MMU-6798695; Neutrophil degranulation. DR BioGRID-ORCS; 68682; 0 hits in 80 CRISPR screens. DR ChiTaRS; Slc44a2; mouse. DR PRO; PR:Q8BY89; -. DR Proteomes; UP000000589; Chromosome 9. DR RNAct; Q8BY89; Protein. DR Bgee; ENSMUSG00000057193; Expressed in vestibular membrane of cochlear duct and 257 other cell types or tissues. DR ExpressionAtlas; Q8BY89; baseline and differential. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB. DR GO; GO:0005739; C:mitochondrion; ISO:MGI. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0015297; F:antiporter activity; IEA:UniProtKB-KW. DR GO; GO:0015220; F:choline transmembrane transporter activity; ISS:UniProtKB. DR GO; GO:0034228; F:ethanolamine transmembrane transporter activity; ISS:UniProtKB. DR GO; GO:0022857; F:transmembrane transporter activity; IBA:GO_Central. DR GO; GO:0015871; P:choline transport; ISS:UniProtKB. DR GO; GO:0034229; P:ethanolamine transport; ISS:UniProtKB. DR GO; GO:0055085; P:transmembrane transport; ISO:MGI. DR InterPro; IPR007603; Choline_transptr-like. DR PANTHER; PTHR12385; CHOLINE TRANSPORTER-LIKE (SLC FAMILY 44); 1. DR PANTHER; PTHR12385:SF34; CHOLINE TRANSPORTER-LIKE PROTEIN 2; 1. DR Pfam; PF04515; Choline_transpo; 1. DR Genevisible; Q8BY89; MM. PE 1: Evidence at protein level; KW Alternative promoter usage; Antiport; Cell membrane; Glycoprotein; KW Membrane; Mitochondrion; Mitochondrion outer membrane; Phosphoprotein; KW Reference proteome; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..706 FT /note="Choline transporter-like protein 2" FT /id="PRO_0000191718" FT TOPO_DOM 1..33 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 34..54 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 55..232 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 233..253 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 254..256 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 257..277 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 278..315 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 316..336 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 337..364 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 365..385 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 386..454 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 455..477 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 478..504 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 505..525 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 526..563 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 564..584 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 585..599 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 600..620 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 621..638 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 639..659 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 660..706 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT MOD_RES 14 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q8IWA5" FT CARBOHYD 187 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19349973, FT ECO:0000269|PubMed:19656770" FT CARBOHYD 200 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19349973, FT ECO:0000269|PubMed:19656770" FT CARBOHYD 417 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 1..12 FT /note="MGKDSQNYYGKH -> MEDDRKDAVY (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:16141072" FT /id="VSP_015432" SQ SEQUENCE 706 AA; 80110 MW; 954AFD393C69A009 CRC64; MGKDSQNYYG KHGTPQKYDP TFKGPIYNRG CTDVICCVLL FLAIVGYVAV GIIAWTHGDP RKVIYPTDSR GEFCGQKGTK NADKPFLFYF NIVKCANPLV LLEFHCPTPQ ICVKQCPDRY LTLLSARNTR DFDYYKQFCV PGFQNNKGVT EILRDGECPA VITPSKPLAQ RCFPAIHASK GVLMVGNETT YEDGHGARKN ITDLVEGAKK ANKILEARQL AMQIFEDYTV SWYWIIIGLV IAMVLSLLFI VLLRFLAGIM VWVMIVMVIL VLGYGIFHCY MEYSRLRGEA GSDVSLVDLG FQTDLRVYLH LRQTWMAFMI ILSILEVVII LLLIFLRKRI LIAIALIKEA SRAVGHVMCS LLYPLVTFFL LCLCIAYWAS TSVFLSTSNT AVYKVVDDTA CPLLRKTCNP ETFPLRNESL QCPTARCQFA FYGGESTYHR ALLGLQIFNA FMFFWLANFV LALGQVTLAG AFASYYWAMR KPDDMPAFPL FSAFGRALRY HTGSLAFGSL ILAIVQIIRV MLEYLDQRLK AAQNKFAKFL MVCLKCCFWC LEKFIKFLNR NAYIMIAIYG TNFCTSARNA FFLLMRNIIR VAVLDKVTDF LFLLGKLLIV GSVGILAFFF FTHRIRIVQD TAPPLNYYWV PILTVIIGSY LIAHGFFSVY GMCVDTLFLC FLEDLERNDG SAERPYFMSS TLKKLLNKTN KKVAES //